Treatment of Androgenetic Alopecia in Males and Females
Public ClinicalTrials.gov record NCT01437163. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Growth of Human Scalp Hair Mediated By Visible Red Light Laser and LED Sources.
Study identification
- NCT ID
- NCT01437163
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Apira Science, Inc.
- Industry
- Enrollment
- 88 participants
Conditions and interventions
Conditions
Interventions
- Laser and/or Light Hair Rejuvenation System Device
- TopHat 655 rejuvenation system Device
Device
Eligibility (public fields only)
- Age range
- 18 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2011
- Primary completion
- Jul 31, 2013
- Completion
- Jul 31, 2013
- Last update posted
- Jul 11, 2016
2011 – 2013
United States locations
- U.S. sites
- 4
- U.S. states
- 2
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Adolfo Fernandez-Obregon, MD | Hoboken | New Jersey | 07030 | — |
| Peter S. Halperin, MD | New York | New York | 10065 | — |
| Raymond J. Lanzafame, MD | Rochester | New York | 14617 | — |
| Jeffrey A. Sklar, MD | Woodbury | New York | 11797 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01437163, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 11, 2016 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01437163 live on ClinicalTrials.gov.